NephroGenex, Inc.
DelistedCIK 1338095fmd_1D6M03KCJ6ZSH237ZBX1Q7C0E1Manufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2005 to Dec 31, 2015, 20 periods
| Line item | FY2006 | FY2007 | FY2008 | FY2009 | FY2010 | FY2011 | FY2012 | FY2013 | FY2014 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Research and development | – | – | – | – | – | – | – | 1 | 11 | 15 |
| Total operating expenses | – | – | – | – | – | – | – | 3 | 17 | 22 |
| Operating income | – | – | – | – | – | – | – | (3) | (17) | (22) |
| Interest expense | – | – | – | – | – | – | – | 0 | 0 | 1 |
| Interest and investment income | – | – | – | – | – | – | – | 0 | 0 | 0 |
| Income tax expense | – | – | – | – | – | – | – | 0 | 0 | 0 |
| Net income | (1) | (8) | (7) | (8) | (6) | (2) | (3) | (6) | (17) | (23) |